drugset / Trial / NCT00472771

INNO-206 in Patients With Small Cell Lung Cancer (SCLC)

NCT00472771

Phase 2 Withdrawn CytRx
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether INNO-206 is effective in the treatment of small cell lung cancer.

Timeline

Start
2008-05
Primary completion
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Aldoxorubicin Small molecule